πŸ‡ΊπŸ‡Έ FDA
Patent

US 7842686

CGRP receptor antagonists

granted A61PA61P1/02A61P1/04

Quick answer

US patent 7842686 (CGRP receptor antagonists) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P1/02, A61P1/04, A61P11/00, A61P11/06